Pro Share Advisors LLC Theravance Biopharma, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$8.22 - $11.59 $4,175 - $5,887
508 Added 4.34%
12,219 $109,000
Q4 2023

Feb 14, 2024
BUY
$8.58 - $11.4 $8,005 - $10,636
933 Added 8.66%
11,711 $131,000
Q3 2023

Nov 13, 2023
SELL
$8.38 - $10.44 $8,245 - $10,272
-984 Reduced 8.37%
10,778 $93,000
Q2 2023

Aug 10, 2023
SELL
$10.16 - $11.92 $6,045 - $7,092
-595 Reduced 4.82%
11,762 $121,000
Q1 2023

May 25, 2023
BUY
$9.87 - $11.44 $121,963 - $141,364
12,357 New
12,357 $134,000
Q4 2022

Feb 02, 2023
BUY
$9.65 - $11.34 $4,303 - $5,057
446 Added 3.3%
13,974 $156,000
Q3 2022

Nov 04, 2022
BUY
$8.39 - $10.22 $3,070 - $3,740
366 Added 2.78%
13,528 $137,000
Q2 2022

Aug 01, 2022
SELL
$8.41 - $10.34 $48,937 - $60,168
-5,819 Reduced 30.66%
13,162 $119,000
Q1 2022

May 10, 2022
SELL
$8.33 - $12.96 $37,551 - $58,423
-4,508 Reduced 19.19%
18,981 $181,000
Q4 2021

Feb 08, 2022
BUY
$7.42 - $11.05 $786 - $1,171
106 Added 0.45%
23,489 $260,000
Q3 2021

Nov 12, 2021
SELL
$6.77 - $14.41 $14,738 - $31,370
-2,177 Reduced 8.52%
23,383 $173,000
Q2 2021

Aug 13, 2021
BUY
$14.52 - $22.46 $60,882 - $94,174
4,193 Added 19.62%
25,560 $371,000
Q1 2021

May 14, 2021
BUY
$16.57 - $21.08 $19,237 - $24,473
1,161 Added 5.75%
21,367 $436,000
Q4 2020

Feb 09, 2021
BUY
$14.89 - $20.16 $64,533 - $87,373
4,334 Added 27.31%
20,206 $359,000
Q3 2020

Nov 13, 2020
SELL
$14.79 - $22.49 $6,803 - $10,345
-460 Reduced 2.82%
15,872 $235,000
Q2 2020

Aug 03, 2020
BUY
$20.64 - $30.69 $116,595 - $173,367
5,649 Added 52.88%
16,332 $343,000
Q1 2020

May 15, 2020
SELL
$17.84 - $31.21 $136,511 - $238,818
-7,652 Reduced 41.73%
10,683 $247,000
Q4 2019

Feb 12, 2020
SELL
$16.12 - $25.89 $32,723 - $52,556
-2,030 Reduced 9.97%
18,335 $475,000
Q3 2019

Nov 12, 2019
SELL
$16.51 - $23.78 $10,104 - $14,553
-612 Reduced 2.92%
20,365 $397,000
Q2 2019

Aug 13, 2019
SELL
$15.6 - $25.15 $40,731 - $65,666
-2,611 Reduced 11.07%
20,977 $343,000
Q1 2019

May 15, 2019
BUY
$22.57 - $28.15 $5,507 - $6,868
244 Added 1.05%
23,588 $535,000
Q4 2018

Feb 14, 2019
SELL
$22.52 - $35.07 $98,389 - $153,220
-4,369 Reduced 15.77%
23,344 $597,000
Q3 2018

Nov 14, 2018
SELL
$22.83 - $32.67 $22,441 - $32,114
-983 Reduced 3.43%
27,713 $905,000
Q2 2018

Aug 13, 2018
SELL
$22.06 - $25.52 $41,031 - $47,467
-1,860 Reduced 6.09%
28,696 $651,000
Q1 2018

May 14, 2018
SELL
$23.37 - $29.71 $111,965 - $142,340
-4,791 Reduced 13.55%
30,556 $741,000
Q4 2017

Feb 14, 2018
BUY
$25.82 - $35.66 $55,693 - $76,918
2,157 Added 6.5%
35,347 $986,000
Q3 2017

Nov 13, 2017
BUY
$23.88 - $34.96 $50,386 - $73,765
2,110 Added 6.79%
33,190 $1.14 Million
Q2 2017

Aug 11, 2017
BUY
N/A
31,080
31,080 $1.24 Million

Others Institutions Holding TBPH

# of Institutions
122
Shares Held
47.3M
Call Options Held
200
Put Options Held
12.8K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $640M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email